Impurity reference standards
Atomoxetine impurities & reference standards
Characterised Atomoxetine impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
39reference materials
1nitrosamine impurities
1isotope-labelled
COAHPLC · NMR · MS on request
(R)-3-Chloro-1-phenyl-1-(2-methylphenoxy)propane
- CAS
- 114446-47-8
- Formula
- C16H17ClO
- MW
- 260.76 g/mol
VQ-043715
N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine Hydrochloride
- CAS
- 873310-28-2
- Formula
- C17H22ClNO
- MW
- 291.8 g/mol
VQ-029248
N-Methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine Hydrochloride
- CAS
- 873310-31-7
- Formula
- C17H22ClNO
- MW
- 291.8 g/mol
VQ-021652
![Phenyl N-methyl-N-[3-(2-methylphenoxy)-3-phenylpropyl]carbamate chemical structure](/media/structures/XQRWVVSMZKGEBO-UHFFFAOYSA-N.svg)
Phenyl N-methyl-N-[3-(2-methylphenoxy)-3-phenylpropyl]carbamate
- CAS
- 93982-97-9
- Formula
- C24H25NO3
- MW
- 375.5 g/mol
VQ-029249
FAQs — Atomoxetine impurities
Which Atomoxetine impurities do you supply?
We list 39 Atomoxetine-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Atomoxetine impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Atomoxetine impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Atomoxetine impurity standards
We reply within one business day with price, pack options, lead time and documentation.